Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of avelumab + axitinib in cancer (Japan, jRCT2080223659)
jRCT2080223659Phase 1Completed
- Start
- Sep 2017
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of avelumab and axitinib in cancer. Started Sep 2017; status: completed.
02
Drugs
avelumabaxitinib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223659.